180 Life Sciences (ATNF) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free ATNF Stock Alerts $1.77 -0.05 (-2.75%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline180 Life Sciences Corp.: 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirementfinanznachrichten.de - March 14 at 1:27 PM180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - March 14 at 1:27 PM180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirementglobenewswire.com - March 14 at 8:30 AMmarketbeat.com - February 28 at 6:07 AM180 Life Sciences Announces 1-For 19 Reverse Stock Split - Quick Factsmarkets.businessinsider.com - February 26 at 10:03 AM180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Planglobenewswire.com - February 26 at 7:00 AM180 Life Sciences Corp.thestreet.com - February 17 at 1:59 AM180 Life Sciences Stock (NASDAQ:ATNF), Quotes and News Summarybenzinga.com - December 20 at 1:02 PM180 Life Sciences Hires Financial Adviser to Help Explore Strategic Alternativesmarketwatch.com - December 4 at 1:39 PM180 Life Sciences Engages Financial Advisor to Explore Strategic Alternativesfinance.yahoo.com - December 4 at 1:39 PM180 Life Sciences Corp.: 180 Life Sciences Announces Review of Strategic Alternativesfinanznachrichten.de - November 28 at 1:21 PM180 Life Sciences Announces Review of Strategic Alternativesfinance.yahoo.com - November 28 at 1:21 PM180 Life Sciences Corp. Common Stock (ATNF)nasdaq.com - October 7 at 10:22 AMInnovative Biotech Company Announces Agreement To Perform CBD Pill Clinical Studybenzinga.com - September 15 at 3:01 PM180 Life Sciences Corp. Announces Closing of $3 Million Public Offeringfinance.yahoo.com - August 14 at 5:17 PM180 Life Sciences Teams Up With Hadassah Hospital To Test A New Formulation Of CBD For Enhanced Oral Uptakebenzinga.com - August 7 at 9:55 PM180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptakefinance.yahoo.com - August 7 at 9:55 PM180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren’s Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDAfinance.yahoo.com - August 3 at 12:38 PM180 Life Sciences Files A Provisional Patent For CBD-Based Appetite Suppressantbenzinga.com - July 31 at 3:12 PM180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetitefinance.yahoo.com - July 31 at 10:11 AM180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placementfinance.yahoo.com - April 10 at 7:45 PM180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placementfinance.yahoo.com - April 5 at 3:14 PMmarketbeat.com - April 5 at 1:04 PMWhy Is 180 Life Sciences (ATNF) Stock Up 30% Today?investorplace.com - April 5 at 9:12 AM180 Life Sciences Announces Presentation at the Gordon Conferencefinance.yahoo.com - February 28 at 1:58 AM180 Life Sciences Announces Presentation at the Gordon Conferencefinance.yahoo.com - February 27 at 8:58 PM180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and Applicationfinance.yahoo.com - February 23 at 10:16 AM180 Life Sciences stock dips as recruitment in trial for Frozen shoulder closes amid challengesseekingalpha.com - February 23 at 10:16 AM180 Life Sciences to get US patent linked to treating hand disorder Dupuytrenseekingalpha.com - February 23 at 10:16 AM180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s Disease Treatment and Applicationfinance.yahoo.com - February 23 at 10:16 AM180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trialbenzinga.com - February 22 at 6:54 PM180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trialfinance.yahoo.com - February 22 at 6:54 PMmarketbeat.com - February 2 at 1:11 PM180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Diseasefinance.yahoo.com - January 25 at 12:48 PM180 Life Sciences up 12% on tumor necrosis factor as target for Dupuytren’s diseasemsn.com - January 25 at 12:48 PM180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Diseasefinance.yahoo.com - January 25 at 12:48 PM180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United Kingdomfinance.yahoo.com - January 17 at 11:19 AMNewman Ferrara LLP Investigating Officers and Directors of 180 Life Sciences Corp. (ATNF)wsj.com - January 10 at 6:46 PM180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - January 5 at 1:18 PM180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s Diseaseau.finance.yahoo.com - January 4 at 9:49 AM180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s Diseasefinance.yahoo.com - January 4 at 9:49 AMThinking about buying stock in Mullen Automotive, SWVL Holdings, 180 Life Sciences, Alibaba, or Pinterest?benzinga.com - January 3 at 1:09 PM180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - December 23 at 12:06 PMWhat's Going On With 180 Life Sciences Shares?msn.com - December 20 at 7:27 PM180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesbenzinga.com - December 20 at 2:26 PM180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - December 20 at 2:26 PMmarketbeat.com - December 20 at 2:14 PMmarketbeat.com - December 20 at 10:54 AMmarketbeat.com - December 20 at 10:43 AMmarketbeat.com - December 19 at 1:52 PM Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. ATNF Media Mentions By Week ATNF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATNF News Sentiment▼0.000.41▲Average Medical News Sentiment ATNF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATNF Articles This Week▼10▲ATNF Articles Average Week Get 180 Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ATNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BXRX News Today PRFX News Today BDRX News Today NBSE News Today SPRC News Today NEPT News Today EVLO News Today GRI News Today EVFM News Today GLMD News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATNF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
